These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15481207)

  • 61. [BCG vaccination: where are we now?].
    Yavuz T; Arbak P; Oztürk CE; Kocabay K
    Tuberk Toraks; 2004; 52(1):47-51. PubMed ID: 15143372
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Vaccines for other neonatal infections: neonatal BCG vaccination against tuberculosis.
    Britton WJ
    Expert Rev Vaccines; 2004 Aug; 3(4):365-9. PubMed ID: 15270636
    [TBL] [Abstract][Full Text] [Related]  

  • 63. What does tuberculin reactivity after bacille Calmette-Guérin vaccination tell us?
    Menzies D
    Clin Infect Dis; 2000 Sep; 31 Suppl 3():S71-4. PubMed ID: 11010826
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Novel tuberculosis vaccination strategies based on understanding the immune response.
    Kaufmann SH
    J Intern Med; 2010 Apr; 267(4):337-53. PubMed ID: 20433580
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Bacille Calmette Guérin vaccination in pre-term infants.
    Sedaghatian MR; Hashem F; Moshaddeque Hossain M
    Int J Tuberc Lung Dis; 1998 Aug; 2(8):679-82. PubMed ID: 9712284
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Does BCG vaccination protect the newborn and young infants?
    ten Dam HG; Hitze KL
    Bull World Health Organ; 1980; 58(1):37-41. PubMed ID: 6991146
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Selective neonatal BCG immunisation in a multiethnic community: poor uptake among white British infants.
    Menon L; Srinivasan R; Alfaham M
    Commun Dis Public Health; 2004 Dec; 7(4):388. PubMed ID: 15779807
    [No Abstract]   [Full Text] [Related]  

  • 68. BCG vaccination in the first year of life protects children of Indian subcontinent ethnic origin against tuberculosis in England.
    Rodrigues LC; Noel Gill O; Smith PG
    J Epidemiol Community Health; 1991 Mar; 45(1):78-80. PubMed ID: 2045751
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The rate of adverse events following BCG vaccination in Poland.
    Krysztopa-Grzybowska K; Paradowska-Stankiewicz I; Lutyńska A
    Przegl Epidemiol; 2012; 66(3):465-9. PubMed ID: 23230718
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Socio-demographic determinants of timely adherence to BCG, Penta3, measles, and complete vaccination schedule in Burkina Faso.
    Schoeps A; Ouédraogo N; Kagoné M; Sié A; Müller O; Becher H
    Vaccine; 2013 Dec; 32(1):96-102. PubMed ID: 24183978
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Chapter 5: Health staff roles and responsibilities, recording and reporting and BCG vaccination.
    ;
    Int J Tuberc Lung Dis; 2007 Feb; 11(2):134-7. PubMed ID: 17263281
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Assessment of the impact of BCG vaccination on tuberculosis incidence in south Asian adult immigrants.
    Chaloner JH; Ormerod LP
    Commun Dis Public Health; 2002 Dec; 5(4):338-40. PubMed ID: 12564256
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prospects for the BCG vaccination programme in France.
    Lévy-Bruhl D
    Euro Surveill; 2006; 11(3):11-4. PubMed ID: 16567881
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Survey of BCG vaccination policy in Europe: 1994-96.
    Trnka L; Dankova D; Zitova J; Cimprichova L; Migliori GB; Clancy L; Zellweger JP
    Bull World Health Organ; 1998; 76(1):85-91. PubMed ID: 9615500
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The effectiveness of BCG vaccination of the newborn against childhood tuberculosis in Bangkok.
    Padungchan S; Konjanart S; Kasiratta S; Daramas S; ten Dam HG
    Bull World Health Organ; 1986; 64(2):247-58. PubMed ID: 3488839
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Barriers to implementation of the new targeted BCG vaccination in France: a cross sectional study.
    Rossignol L; Guthmann JP; Kernéis S; Aubin-Auger I; Lasserre A; Chauvin P; Pelat C; Hanslik T; Lévy-Bruhl D; Blanchon T
    Vaccine; 2011 Jul; 29(32):5232-7. PubMed ID: 21609744
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Role of BCG in the enlarged program of vaccination].
    Guérin N
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):843-8. PubMed ID: 1819432
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [BCG vaccination coverage in children born after the end of compulsory BCG vaccination and followed in maternal and child health clinics in France: a national survey 2009].
    Guthmann JP; Fonteneau L; Desplanques L; Lévy-Bruhl D
    Arch Pediatr; 2010 Sep; 17(9):1281-7. PubMed ID: 20591630
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Where do we stand with BCG vaccination programme in Japan?].
    Mori T
    Kekkaku; 2001 Apr; 76(4):385-97. PubMed ID: 11398330
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Socio-economic determinants and inequities in coverage and timeliness of early childhood immunisation in rural Ghana.
    Gram L; Soremekun S; ten Asbroek A; Manu A; O'Leary M; Hill Z; Danso S; Amenga-Etego S; Owusu-Agyei S; Kirkwood BR
    Trop Med Int Health; 2014 Jul; 19(7):802-11. PubMed ID: 24766425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.